Titan America SA Common Shares (TTAM)
14.65
-0.20 (-1.35%)
NYSE · Last Trade: Oct 12th, 11:15 PM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025